Filing Details
- Accession Number:
- 0001127602-22-021203
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-17 16:30:53
- Reporting Period:
- 2022-08-15
- Accepted Time:
- 2022-08-17 16:30:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1531048 | Inari Medical Inc. | NARI | Surgical & Medical Instruments & Apparatus (3841) | 452902923 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1644989 | Hill, Mitch C. | C/O Inari Medical, Inc. 6001 Oak Canyon Irvine CA 92618 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-15 | 7,500 | $0.46 | 86,399 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-08-15 | 1,394 | $80.36 | 85,005 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 1,100 | $80.99 | 83,905 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 1,814 | $82.61 | 82,091 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 3,192 | $83.43 | 78,899 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2022-08-15 | 7,500 | $0.00 | 7,500 | $0.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
191,977 | 2029-04-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,600 | Indirect | By Spouse |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021
- This transaction was executed in multiple trades at prices ranging from $79.77 to $80.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $80.77 to $81.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $82.00 to $82.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $83.01 to $83.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Options vested with respected with 25% of the underlying shares on April 30,2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.